Subgroup analyses according to molecular subtype of breast cancer in patients treated with chemotherapy showed significant influences of high NR1D1 expression on OS (P = 0.002) and DFS (P = 0.007) in TNBC patients who received chemotherapy (Fig. 3). Here, NR1D1 is linked to breast carcinoma.